Literature DB >> 10862228

Folate and vitamin B12 status of women in Newfoundland at their first prenatal visit.

J D House1, S B March, S Ratnam, E Ives, J T Brosnan, J K Friel.   

Abstract

BACKGROUND: Newfoundland has one of the highest rates of neural tube defects in North America. Given the association between low maternal folic acid levels and neural tube defects, a cross-sectional study was conducted to obtain base-line data on the folate and vitamin B12 status of a sample of women in Newfoundland who were pregnant.
METHODS: Blood samples were collected between August 1996 and July 1997 from 1424 pregnant women in Newfoundland during the first prenatal visit (at approximately 16 weeks' gestation); this represented approximately 25% of the women in Newfoundland who were pregnant during this period. The samples were analysed for serum folate, vitamin B12, red blood cell folate and homocysteine.
RESULTS: Median values for serum folate, red blood cell folate and serum vitamin B12 were 25 nmol/L, 650 nmol/L and 180 pmol/L, respectively. On the basis of the interpretive criteria used for red blood cell folate status, 157 (11.0%) of the 1424 women were deficient (< 340 nmol/L) and a further 180 (12.6%) were classified as indeterminate (340-420 nmol/L). Serum homocysteine levels, measured in subsets of the red blood cell folate status groups, supported the inadequate folate status. Serum vitamin B12 levels of 621 (43.6%) women were classified as deficient or marginal; however, the validity of the interpretive criteria for pregnant women is questionable.
INTERPRETATION: A large proportion of pregnant women surveyed in Newfoundland in 1997 had low red blood cell folate levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862228      PMCID: PMC1231334     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  19 in total

1.  High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum.

Authors:  B Vester; K Rasmussen
Journal:  Eur J Clin Chem Clin Biochem       Date:  1991-09

Review 2.  Folate status during pregnancy and lactation.

Authors:  D L O'Connor
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

3.  Neural tube defects in Newfoundland.

Authors:  M F Frecker
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

4.  The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency.

Authors:  S P Stabler; J Lindenbaum; R H Allen
Journal:  J Nutr       Date:  1996-04       Impact factor: 4.798

5.  Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels.

Authors:  J Metz; K McGrath; M Bennett; K Hyland; T Bottiglieri
Journal:  Am J Hematol       Date:  1995-04       Impact factor: 10.047

6.  Nutritional patterns of mothers of children with neural tube defects in Newfoundland.

Authors:  J K Friel; M Frecker; F C Fraser
Journal:  Am J Med Genet       Date:  1995-01-16

7.  Periconceptional folic acid exposure and risk of occurrent neural tube defects.

Authors:  M M Werler; S Shapiro; A A Mitchell
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

8.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

9.  Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects.

Authors:  P N Kirke; A M Molloy; L E Daly; H Burke; D G Weir; J M Scott
Journal:  Q J Med       Date:  1993-11

10.  FOLIC ACID AND VITAMIN B12 LEVELS IN PREGNANCY AND THEIR RELATION TO MEGALOBLASTIC ANAEMIA.

Authors:  E W BALL; C GILES
Journal:  J Clin Pathol       Date:  1964-03       Impact factor: 3.411

View more
  8 in total

1.  Folic acid: the opportunity that still exists; [comment].

Authors:  J G Hall
Journal:  CMAJ       Date:  2000-05-30       Impact factor: 8.262

2.  Folic acid supplementation: more work is needed.

Authors:  N K Björklund; J A Evans; C R Greenberg
Journal:  CMAJ       Date:  2000-10-31       Impact factor: 8.262

3.  High frequency of maternal vitamin B12 deficiency as an important cause of infantile vitamin B12 deficiency in Sanliurfa province of Turkey.

Authors:  Ahmet Koc; Abdurrahim Kocyigit; Mustafa Soran; Nihat Demir; Eylem Sevinc; Ozcan Erel; Zeki Mil
Journal:  Eur J Nutr       Date:  2006-04-06       Impact factor: 5.614

Review 4.  Prevalence of multiple micronutrient deficiencies amongst pregnant women in a rural area of Haryana.

Authors:  Priyali Pathak; Umesh Kapil; Suresh Kumar Kapoor; Renu Saxena; Anand Kumar; Nandita Gupta; Sada Nand Dwivedi; Rajvir Singh; Preeti Singh
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

5.  Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry.

Authors:  Kimberly A Godwin; Barbara Sibbald; Tanya Bedard; Boris Kuzeljevic; R Brian Lowry; Laura Arbour
Journal:  Can J Public Health       Date:  2008 Jul-Aug

6.  Iron, folate and vitamin B12 levels in first trimester pregnancies in the Southwest region of Turkey.

Authors:  Aysun Karabulut; Osman Sevket; Ayhan Acun
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-01

7.  The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein.

Authors:  Natalie K Björklund; Jane A Evans; Cheryl R Greenberg; Lorne E Seargeant; Carol E Schneider; Bernard N Chodirker
Journal:  Reprod Biol Endocrinol       Date:  2004-09-07       Impact factor: 5.211

8.  A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects.

Authors:  Shiliang Liu; Roy West; Edward Randell; Linda Longerich; Kathleen Steel O'connor; Helen Scott; Marian Crowley; Angeline Lam; Victor Prabhakaran; Catherine McCourt
Journal:  BMC Pregnancy Childbirth       Date:  2004-09-27       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.